A collaboration with Loxo@Lilly, led by PC3I Associate Director Charu Aggarwal, will expand use of a novel strategy to help patients with lung cancer receive important genetic testing.
We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
The University of Pennsylvania (Penn) Telehealth ReseArch Center of Excellence (Penn TRACE), based at the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center, is one of four NCI Telehealth Research Centers of Excellence dedicated to advancing the nation's telehealth research agenda focused on improving cancer-related care and outcomes, with support from the White House Cancer Moonshot.
Electronic Health Record Nudges to Improve Equitable Genetic Screening in Young-Onset Colorectal Cancer
This project leverages behavioral economics in order to improve referral and uptake of germline genetic evaluations for patients with young-onset colorectal cancer recommended by the NCCN to identify the presence of a hereditary cancer syndrome.
Enhanced Risk Communication to Promote Lung Cancer Screening in Philadelphia’s Most Environmentally Burdened Communities
Project PLUS promotes lung cancer screening within Philadelphia’s most environmentally burdened communities through enhanced risk communication, with the intent to increase screening rates and reduce disparities.
Based on an identified critical need to increase the frequency and improve the timeliness of serious illness conversations (SICs), we are testing behavioral economics-informed multilevel implementation strategies for early SICs, with health equity as a driving force.